(Q45281373)

11 December 2017

CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition (English)

1 reference

11 December 2017

0 references

0 references

0 references

0 references

2

Raphael Mechoulam

1 reference

11 December 2017

David Panikashvili

1

1 reference

11 December 2017

Sara M Beni

series ordinal

3

1 reference

11 December 2017

Alexander Alexandrovich

series ordinal

4

1 reference

11 December 2017

Esther Shohami

series ordinal

5

1 reference

11 December 2017

1 April 2005

1 reference

Journal of Cerebral Blood Flow & Metabolism

11 December 2017

1 reference

11 December 2017

25

1 reference

11 December 2017

4

1 reference

11 December 2017

477-484

1 reference

Function and activation of NF-kappa B in the immune system

11 December 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-kappaB and AP-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

The "dark side" of endocannabinoids: a neurotoxic role for anandamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Leptin-regulated endocannabinoids are involved in maintaining food intake

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Critical role of the endogenous cannabinoid system in mouse pup suckling and growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Cannabinoids and neuroprotection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Putative neuroprotective actions of N-acyl-ethanolamines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo-controlled, phase II clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Free radical pathways in CNS injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

IkappaBbeta, but not IkappaBalpha, functions as a classical cytoplasmic inhibitor of NF-kappaB dimers by masking both NF-kappaB nuclear localization sequences in resting cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Increased severity of stroke in CB1 cannabinoid receptor knock-out mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

The Rel/NF-kappa B family: friend and foe.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Dexanabinol (HU-211): A nonpsychotropic cannabinoid with neuroprotective properties

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Comparative anti-phlogistic activity of Δ9-tetrahydrocannabinol, hydrocortisone and aspirin in various rat paw edema models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Temporal profile of cerebrospinal fluid glutamate, interleukin-6, and tumor necrosis factor-alpha in relation to brain edema and contusion following controlled cortical impact injury in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in picrotoxinin-administered rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

IkappaB family members function by different mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Neuroprotection by Delta9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Exogenous anandamide protects rat brain against acute neuronal injury in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Acute neuronal injury, excitotoxicity, and the endocannabinoid system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Activation of AP-1 and Nuclear Factor-κB Transcription Factors Is Involved in Hydrogen Peroxide-Induced Apoptotic Cell Death of Olligodendrocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Nuclear factor-kappaB as a therapeutic target in critical care medicine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600047

7 January 2021

Identifiers

DOI

10.1038/SJ.JCBFM.9600047

1 reference

11 December 2017

1 reference